STOCK TITAN

111 Inc - YI STOCK NEWS

Welcome to our dedicated news page for 111 (Ticker: YI), a resource for investors and traders seeking the latest updates and insights on 111.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect 111's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of 111's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.27%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.33%
Tags
covid-19
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.73%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.5%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.53%
Tags
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
partnership
111 Inc

Nasdaq:YI

YI Rankings

YI Stock Data

92.39M
65.94M
16.72%
28.28%
0.04%
Pharmacies and Drug Stores
Retail Trade
Link
China (Mainland)
Shanghai

About YI

111, inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the people's republic of china. it operates through two segments, b2b and b2c. the company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. its product portfolio comprises prescription and over-the counter drugs, such as western and traditional chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. the company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 drug mall, includin